Alignment Healthcare, INC Form 4 insider transactions

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold shares of common stock on March 7, 2025, under a pre-arranged 10b5-1 trading plan.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold 55,403 shares to cover tax obligations following the vesting of performance share units (PSUs).

Dawn Christine Maroney, President of Alignment Healthcare, acquired 1,020,442 shares of common stock through the vesting of performance share units (PSUs) and subsequently sold 278,917 shares to cover tax obligations.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, reports the acquisition and disposal of common stock following the vesting of performance share units (PSUs).

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares to cover tax obligations after performance share units vested, while also selling shares under a 10b5-1 plan.

Alignment Healthcare's CEO, John Kao, reports acquiring shares from vested performance share units (PSUs) and selling shares to cover tax obligations.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold shares to cover tax obligations after performance share units vested due to the achievement of performance objectives.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, acquired 474,208 shares of common stock through the vesting of performance share units (PSUs) and subsequently sold 86,659 shares to cover tax obligations.

Dawn Maroney, President of Alignment Healthcare, reports gifting 13,647 shares of common stock to family members on March 3, 2025.

Dawn Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock on February 18, 2025, at a weighted-average price of $13.7157 per share.

Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $14.2256 on February 11, 2025, according to a Form 4 filing.

Hakan Kardes, Chief Experience Officer at Alignment Healthcare, sold 14,500 shares of common stock at a weighted average price of $14.9846 per share under a pre-arranged 10b5-1 trading plan.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 10,500 shares of common stock at an average price of $14.9876 per share on January 21, 2025, under a pre-arranged 10b5-1 trading plan.

Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock at a weighted average price of $13.6128 per share on January 15, 2025, under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare's CEO, John E. Kao, sold a total of 90,000 shares of common stock on January 13, 2025, under a pre-arranged 10b5-1 trading plan.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock at an average price of $11.3336 on December 16, 2024, according to a Form 4 filing with the SEC.

Alignment Healthcare's CEO, John E. Kao, sold 90,000 shares of common stock at an average price of $11.6521 per share, according to a recent SEC filing.

Alignment Healthcare's Chief Operating Officer, Sebastian Burzacchi, sold 8,550 shares to cover tax obligations related to vesting restricted stock units.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 62,574 shares of common stock at a weighted average price of $12.2027 per share under a pre-arranged 10b5-1 trading plan.

Hakan Kardes, Chief Experience Officer at Alignment Healthcare, sold 35,000 shares of common stock at a weighted average price of $12.804.

Dawn Maroney, President of Markets at Alignment Healthcare, gifted 30,000 shares of common stock to a charitable donor advised fund.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock at a weighted average price of $11.352 per share on November 15, 2024, under a pre-arranged 10b5-1 trading plan.

Joseph S. Konowiecki, a director at Alignment Healthcare, sold 6,920 shares of common stock to cover tax obligations related to vesting restricted stock units.

Alignment Healthcare's Chief Financial Officer, Robert Thomas Freeman, sold 30,500 shares of common stock at a price of $13.4215 per share on November 11, 2024, under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare's CEO, John E. Kao, sold 90,000 shares of common stock at $13.4216 per share under a pre-arranged 10b5-1 trading plan.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold a portion of his holdings in two transactions on November 1st and 4th, 2024.

Robert Freeman, CFO of Alignment Healthcare, executed sales of common stock on October 29 and October 31, 2024, under a pre-arranged 10b5-1 trading plan.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock on October 15, 2024, under a pre-arranged 10b5-1 trading plan.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 30,500 shares of common stock at an average price of $11.504 on October 14, 2024, under a pre-arranged 10b5-1 trading plan.